The Quest for Improving Treatment of Cancer of Unknown Primary (CUP) Through Molecularly-Driven Treatments: A Systematic Review

Background: Carcinomas of unknown primary (CUP) account for 3–5% of all malignancy and, despite a reduction in incidence, the overall survival has not improved over the last decade. Chemotherapy regimens have not provided encouraging results. New diagnostic technologies, such as next generation sequ...

Descripción completa

Detalles Bibliográficos
Autores principales: Lombardo, Roberta, Tosi, Federica, Nocerino, Annunziata, Bencardino, Katia, Gambi, Valentina, Ricotta, Riccardo, Spina, Francesco, Siena, Salvatore, Sartore-Bianchi, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225282/
https://www.ncbi.nlm.nih.gov/pubmed/32457826
http://dx.doi.org/10.3389/fonc.2020.00533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225282/
https://www.ncbi.nlm.nih.gov/pubmed/32457826
http://dx.doi.org/10.3389/fonc.2020.00533

Ejemplares similares